Alpha Cognition Inc. (NasdaqCM: ACOG)
Health Care · Biotechnology · US
$9.04
-0.66% today · +28.3% 1Y
Alpha Cognition Inc. (NasdaqCM: ACOG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $196.87M and employs 71 people.
Over the last twelve months the share price has gained 28.3%, trading between 4.50 and 10.14.
Tweenvest scores Alpha Cognition Inc. across four factors: quality 40/100, value 61/100. Its strongest factor is value.
ACOG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $196.87M
- Revenue (TTM)
- $15.26M
- P/E
- —
- EPS
- -1.05
- Dividend yield
- —
- Beta (5Y)
- 2.23
- 52-week high
- $10.14
- 52-week low
- $4.50
- Avg volume (3M)
- —
- Shares outstanding
- 21.78M
- Employees
- 71
- Next earnings
- —
About Alpha Cognition Inc.
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
- ISIN
- CA02074J5017
- Founded
- 2000
- Listed since
- Nov 12, 2024
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Biomm S.A.BOVESPA: BIOM3 | $201.65M | R$7.34 | +13.80% |
| Cue Biopharma, Inc.NasdaqCM: CUE | $200.93M | $27.30 | -1.30% |
| Whitehawk Therapeutics, Inc.NasdaqCM: WHWK | $200.67M | $3.52 | -4.86% |
| S.Biomedics Co., Ltd.KOSDAQ: A304360 | $200.37M | ₩21,750.00 | +4.07% |
| Thor Medical ASAOB: TRMED | $196.75M | Nkr4.46 | -1.00% |
| IntoCell, Inc.KOSDAQ: A287840 | $193.53M | ₩17,320.00 | -4.04% |
| Precision BioSciences, Inc.NasdaqCM: DTIL | $185.48M | $6.72 | +4.51% |
| Adagene Inc.NasdaqGM: ADAG | $185.32M | $2.76 | -3.16% |
Figures last refreshed Oct 11, 2026.